Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in Clin Lung Cancer Retrieve available abstracts of 118 articles: HTML format Text format

Single Articles

January 2012
1. KIM YH , Sumiyoshi S, Hashimoto S, Masago K, et al
   Expressions of Insulin-Like Growth Factor Receptor-1 and Insulin-Like Growth Factor Binding Protein 3 in Advanced Non-Small-Cell Lung Cancer.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. HYOGOTANI A , Ito KI, Yoshida K, Izumi H, et al
   Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GRIDELLI C , Brodowicz T, Langer CJ, Peterson P, et al
   Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non-Small-Cell Lung Cancer.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. TAKATANI H , Nakamura Y, Nagashima S, Soda H, et al
   Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non-Small-Cell Lung Cancer.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. HOPPE BS , Flampouri S, Henderson RH, Pham D, et al
   Proton Therapy With Concurrent Chemotherapy for Non-small-cell Lung Cancer: Technique and Early Results.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. GIROUX LEPRIEUR E , Labrune S, Giraud V, Gendry T, et al
   Delay Between the Initial Symptoms, the Diagnosis and the Onset of Specific Treatment in Elderly Patients With Lung Cancer.
   Clin Lung Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
7. PENG Z , Liu Q, Li M, Han M, et al
   Comparison of (11)C-Choline PET/CT and Enhanced CT in the Evaluation of Patients With Pulmonary Abnormalities and Locoregional Lymph Node Involvement in Lung Cancer.
   Clin Lung Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. JIANG W , Pang XG, Wang Q, Shen YX, et al
   Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection.
   Clin Lung Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KONTIC M , Stojsic J, Jovanovic D, Bunjevacki V, et al
   Aberrant Promoter Methylation of CDH13 and MGMT Genes is Associated With Clinicopathologic Characteristics of Primary Non-Small-Cell Lung Carcinoma.
   Clin Lung Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TOGASHI Y , Masago K, Handa T, Tanizawa K, et al
    Prognostic Significance of Preexisting Interstitial Lung Disease in Japanese Patients with Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. REUNGWETWATTANA T , Weroha SJ, Molina JR
    Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MITCHELL P , Mok T, Barraclough H, Strizek A, et al
    Smoking History As a Predictive Factor of Treatment Response in Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CARTER DL , Garfield D, Hathorn J, Mundis R, et al
    A Randomized Phase III Trial of Combined Paclitaxel, Carboplatin, and Radiation Therapy Followed by Weekly Paclitaxel or Observation for Patients With Locally Advanced Inoperable Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HANAGIRI T , Takenaka M, Oka S, Shigematsu Y, et al
    Results of a Surgical Resection for Patients With Stage IV Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ZHANG XQ , Chen GP, Wu T, Yan JP, et al
    Expression and Clinical Significance of Ezrin in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
16. SKOURA E , Datseris IE, Platis I, Oikonomopoulos G, et al
    Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. NAKAGAWA M , Uramoto H, Oka S, Chikaishi Y, et al
    Clinical Significance of IGF1R Expression in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. ZHANG LQ , Jiang F, Xu L, Wang J, et al
    The Role of Cyclin D1 Expression and Patient's Survival in Non-Small-Cell Lung Cancer: A Systematic Review With Meta-Analysis.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. CAO JQ , Rodrigues GB, Louie AV, Zaric GS, et al
    Systematic Review of the Cost-Effectiveness of Positron-Emission Tomography in Staging of Non-Small-Cell Lung Cancer and Management of Solitary Pulmonary Nodules.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MINA N , Soubani AO, Cote ML, Suwan T, et al
    The Relationship Between Chronic Obstructive Pulmonary Disease and Lung Cancer in African American Patients.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. LAI SW , Liao KF, Chen PC, Tsai PY, et al
    Antidiabetes Drugs Correlate With Decreased Risk of Lung Cancer: A Population-Based Observation in Taiwan.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. COHEN EE , Subramanian J, Gao F, Szeto L, et al
    Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. GADGEEL SM
    Safety Profile and Tolerability of Antiangiogenic Agents in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. PETRELLI F , Borgonovo K, Cabiddu M, Barni S, et al
    Efficacy of EGFR Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated Non-Small Cell-Lung Cancer: A Meta-Analysis of 13 Randomized Trials.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. WANG J , Welch K, Wang L, Kong FM, et al
    Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non-Small Cell Lung Cancer: A Meta-Analysis.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
26. PALLIS AG , Voutsina A, Kentepozidis N, Giassas S, et al
    A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GASPAR LE , McNamara EJ, Gay EG, Putnam JB, et al
    Small-Cell Lung Cancer: Prognostic Factors and Changing Treatment Over 15 Years.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
28. SEMRAD TJ , Mack PC
    Fibroblast Growth Factor Signaling in Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ASAHINA H , Sekine I, Horinouchi H, Nokihara H, et al
    Retrospective Analysis of Third-Line and Fourth-Line Chemotherapy for Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. ZHAO Y , Li Y, Lu H, Chen J, et al
    Association of copy number loss of CDKN2B and PTCH1 with poor overall survival in patients with pulmonary squamous cell carcinoma.
    Clin Lung Cancer. 2011;12:328-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LI Y , Chen KZ, Wang J
    Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people.
    Clin Lung Cancer. 2011;12:313-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
32. SPIRA AI , Iannotti NO, Savin MA, Neubauer M, et al
    A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MASSABEAU C , Filleron T, Wakil G, Rouquette I, et al
    The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CARBONE DP , Felip E
    Adjuvant Therapy in Non-Small Cell Lung Cancer: Future Treatment Prospects and Paradigms.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. ORTUZAR W , Hanna N, Pennella E, Peng G, et al
    Brain Metastases as the Primary Site of Relapse in Two Randomized Phase III Pemetrexed Trials in Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. GALETTA D , Pisconti S, Cinieri S, Pappagallo GL, et al
    Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life-Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BOSCH-BARRERA J , Quer N, Brunet J
    Costs and Ethical Issues Related to First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer: Considerations From a Public Healthcare System Perspective.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. XU J , Yin Z, Gao W, Liu L, et al
    Meta-Analysis on the Association Between Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Risk.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
39. MANI D , Haigentz M Jr, Aboulafia DM
    Lung Cancer in HIV Infection.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. NAKAJIMA T , Yasufuku K, Suzuki M, Hiroshima K, et al
    Thymidylate Synthase, Dihydropyrimidine Dehydrogenase, Thymidine Phosphorylase, Orotate Phosphoribosyltransferase mRNA Expression in Lung Cancer Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MASAGO K , Togashi Y, Fukudo M, Terada T, et al
    Plasma and Pleural Fluid Pharmacokinetics of Erlotinib and its Active Metabolite OSI-420 in Patients with Non-Small-Cell Lung Cancer with Pleural Effusion.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. DAS M , Donington JS, Murphy J, Kozak M, et al
    Results from a Single Institution Phase II Trial of Concurrent Docetaxel/Carboplatin/Radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/Carboplatin in Stage III Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. COURAUD S , Fournel P, Moro-Sibilot D, Perol M, et al
    Are Clinical Guidelines Applied in Routine Daily Practice? A French Regional Survey of Physicians' Clinical Practices in Lung Cancer Management (EPOTRA).
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. NICHOLS RC , Huh SN, Henderson RH, Mendenhall NP, et al
    Proton Radiation Therapy Offers Reduced Normal Lung and Bone Marrow Exposure for Patients Receiving Dose-Escalated Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer: A Dosimetric Study.
    Clin Lung Cancer. 2011;12:252-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. WERNER-WASIK M , Paulus R, Curran WJ Jr, Byhardt R, et al
    Acute Esophagitis and Late Lung Toxicity in Concurrent Chemoradiotherapy Trials in Patients with Locally Advanced Non-Small-Cell Lung Cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) Database.
    Clin Lung Cancer. 2011;12:245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. IRANZO V , Sirera R, Bremnes RM, Blasco A, et al
    Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients.
    Clin Lung Cancer. 2011;12:224-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. GADGEEL SM , Ivy P, Chen W, Mauer J, et al
    Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials.
    Clin Lung Cancer. 2011;12:218-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. ADJEI AA , Blumenschein GR Jr, Mandrekar S, Hillman S, et al
    Long-term safety and tolerability of sorafenib in patients with advanced non-small-cell lung cancer: a case-based review.
    Clin Lung Cancer. 2011;12:212-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. GROSE D , Devereux G, Milroy R
    Comorbidity in lung cancer: important but neglected. A review of the current literature.
    Clin Lung Cancer. 2011;12:207-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. OKAMOTO J , Kratz JR, Hirata T, Mikami I, et al
    Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
    Clin Lung Cancer. 2011;12:237-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
51. ROTH JA , Carlson JJ
    Prognostic Role of ERCC1 in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. GRIDELLI C , Bennouna J, de Castro J, Dingemans AM, et al
    Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non-Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. LEE P , Bazan JG, Lavori PW, Weerasuriya DK, et al
    Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
54. YOUNT S , Beaumont J, Rosenbloom S, Cella D, et al
    A Brief Symptom Index for Advanced Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PENNELL NA
    Integration of EGFR Inhibitors and Conventional Chemotherapy in the Treatment of Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. MAZZOCCOLI G , Sothern RB, Pazienza V, Piepoli A, et al
    Circadian Aspects of Growth Hormone-Insulin-Like Growth Factor Axis Function in Patients With Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. EDELMAN MJ , Shvartsbeyn M
    Epothilones in Development for Non-Small-Cell Lung Cancer: Novel Anti-Tubulin Agents With the Potential to Overcome Taxane Resistance.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MOUNTZIOS G , Ramfidis V, Terpos E, Syrigos KN, et al
    Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. KURAHARA Y , Kawaguchi T, Tachibana K, Atagi S, et al
    Small-Cell Lung Cancer in Never-Smokers: A Case Series With Information on Family History of Cancer and Environmental Tobacco Smoke.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. TSAO AS , Wei W, Kuhn E, Spencer L, et al
    Immunohistochemical Overexpression of Platelet-Derived Growth Factor Receptor-Beta (PDGFR-beta) is Associated With PDGFRB Gene Copy Number Gain in Sarcomatoid Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LANGER CJ
    Clinical Evidence on the Undertreatment of Older and Poor Performance Patients Who Have Advanced Non-Small-Cell Lung Cancer: Is There a Role for Targeted Therapy in These Cohorts?
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. JANTUS-LEWINTRE E , Sirera R, Cabrera A, Blasco A, et al
    Analysis of the Prognostic Value of Soluble Epidermal Growth Factor Receptor Plasma Concentration in Advanced Non-Small-Cell Lung Cancer Patients.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. ASAMI K , Koizumi T, Hirai K, Ameshima S, et al
    Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. AYDINER A , Sen F, Saglam EK, Oral EN, et al
    Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SUDHINDRA A , Ochoa R, Santos ES
    Biomarkers, Prediction, and Prognosis in Non-Small-Cell Lung Cancer: A Platform for Personalized Treatment.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. GIULIANI ME , Atallah S, Sun A, Bezjak A, et al
    Clinical Outcomes of Extensive Stage Small Cell Lung Carcinoma Patients Treated With Consolidative Thoracic Radiotherapy.
    Clin Lung Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. MONTGRAIN PR , Deftos LJ, Arenberg D, Tipps A, et al
    Prognostic implications of parathyroid hormone-related protein in males and females with non-small-cell lung cancer.
    Clin Lung Cancer. 2011;12:197-205.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SPIGEL DR , Greco FA, Burris HA 3rd, Shipley DL, et al
    A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011;12:187-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CEDRES S , Nunez I, Longo M, Martinez P, et al
    Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2011;12:172-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. YANG H , Wang W, Zhang Y, Zhao J, et al
    The Role of NF-E2-Related Factor 2 in Predicting Chemoresistance and Prognosis in Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011;12:166-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. HORN L , Zhao Z, Sandler A, Johnson D, et al
    A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2011;12:161-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. KARAMPEAZIS A , Vamvakas L, Agelidou A, Kentepozidis N, et al
    Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study.
    Clin Lung Cancer. 2011;12:155-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. MCKEAGE MJ
    Clinical trials of vascular disrupting agents in advanced non-small-cell lung cancer.
    Clin Lung Cancer. 2011;12:143-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. DENG B , Tan QY, Fan XQ, Jiang YG, et al
    Clinical value of assaying tumor supplied group of factor/tumor specific growth factor in patients with solitary pulmonary nodule.
    Clin Lung Cancer. 2011;12:192-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. NATH SK , Sandhu AP, Jensen L, Kim D, et al
    Frameless image-guided stereotactic body radiation therapy for lung tumors with 4-dimensional computed tomography or 4-dimensional positron emission tomography/ computed tomography.
    Clin Lung Cancer. 2011;12:180-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. BOBBA RK , Holly JS, Loy T, Perry MC, et al
    Scar carcinoma of the lung: a historical perspective.
    Clin Lung Cancer. 2011;12:148-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
77. FARINA G , Longo F, Martelli O, Pavese I, et al
    Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non-Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Recepto
    Clin Lung Cancer. 2011;12:138-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. QIAN Q , Zhan P, Yu L, Shi Y, et al
    Baseline levels and decrease in serum soluble intercellular adhesion molecule-1 during chemotherapy predict objective response and survival in patients who have advanced non-small-cell lung cancer.
    Clin Lung Cancer. 2011;12:131-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. GORE E , Bae K, Langer C, Extermann M, et al
    Phase I/II Trial of a COX-2 Inhibitor With Limited Field Radiation for Intermediate Prognosis Patients Who Have Locally Advanced Non-Small-Cell Lung Cancer: Radiation Therapy Oncology Group 0213.
    Clin Lung Cancer. 2011;12:125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. LIE CH , Chang HC, Chao TY, Chung YH, et al
    First- or Second-line Gefitinib Therapy in Unknown Epidermal Growth Factor Receptor Mutants of Non-Small-Cell Lung Cancer Patients Treated in Taiwan.
    Clin Lung Cancer. 2011;12:116-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. DONNEM T , Andersen S, Al-Saad S, Al-Shibli K, et al
    Prognostic Impact of Angiogenic Markers in Non-Small-Cell Lung Cancer is Related to Tumor Size.
    Clin Lung Cancer. 2011;12:106-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. PALLIS AG , Syrigos K, Kotsakis A, Karachaliou N, et al
    Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non-Small-Cell Lung Cancer Pretreated With Non-Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study.
    Clin Lung Cancer. 2011;12:100-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. MORGENSZTERN D , Pennell NA, Subramanian J, Govindan R, et al
    Summary of presentations from the 46th annual meeting of the american society of clinical oncology (2010): focus on developmental therapeutics related to lung cancer.
    Clin Lung Cancer. 2011;12:94-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. HADDADIN S , Perry MC
    History of small-cell lung cancer.
    Clin Lung Cancer. 2011;12:87-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. BAGULEY BC
    Preclinical efficacy of vascular disrupting agents in non-small-cell lung cancer.
    Clin Lung Cancer. 2011;12:81-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
86. GRIDELLI C , Rossi A, Venturino P, de Marinis F, et al
    Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non-Smal
    Clin Lung Cancer. 2011;12:70-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. NAGEL S , Kellner O, Engel-Riedel W, Guetz S, et al
    Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide.
    Clin Lung Cancer. 2011;12:62-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MASAGO K , Fujita S, Togashi Y, Kim YH, et al
    Clinicopathologic factors affecting the progression-free survival of patients with advanced non-small-cell lung cancer after gefitinib therapy.
    Clin Lung Cancer. 2011;12:56-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. YUE W , Zhao X, Zhang L, Xu S, et al
    Cell cycle protein cyclin y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
    Clin Lung Cancer. 2011;12:43-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. GATELY K , Collins I, Forde L, Al-Alao B, et al
    A Role for IGF-1R-Targeted Therapies in Small-Cell Lung Cancer?
    Clin Lung Cancer. 2011;12:38-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. LARA PN JR , Longmate J, Reckamp K, Gitlitz B, et al
    Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.
    Clin Lung Cancer. 2011;12:33-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MAHTANI R , Khan R, Jahanzeb M
    The potential application of zoledronic Acid as anticancer therapy in patients with non-small-cell lung cancer.
    Clin Lung Cancer. 2011;12:26-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. GAO W , Liu L, Lu X, Shu Y, et al
    Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non-Small-Cell Lung Carcinoma.
    Clin Lung Cancer. 2011;12:14-7.
    PubMed     Text format     Related articles   
    
    
    
    
94. CIG MEDIA GROUP
    CLINICAL Lung Cancer.
    Clin Lung Cancer. 2011;12:6-9.
    PubMed     Text format     Related articles   
    
    
    
    
95. MATSUI Y , Hiraki T, Mimura H, Gobara H, et al
    Role of computed tomography fluoroscopy-guided cutting needle biopsy of lung lesions after transbronchial examination resulting in negative diagnosis.
    Clin Lung Cancer. 2011;12:51-5.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
96. LANGER CJ
    Selected trials in small-cell lung cancer.
    Clin Lung Cancer. 2010;11:429-30.
    PubMed     Text format     Related articles   
    
    
    
    
97. MAHESH S , Saxena A, Qiu X, Perez-Soler R, et al
    Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity.
    Clin Lung Cancer. 2010;11:405-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. D'JAEN GA , Pantanowitz L, Bower M, Buskin S, et al
    Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
    Clin Lung Cancer. 2010;11:396-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. LEVY B , Drilon A, Siu K, Grossbard M, et al
    Extended-duration therapy in advanced non-small-cell lung cancer: promise and pitfalls.
    Clin Lung Cancer. 2010;11:383-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. GRIDELLI C , Rossi A, Maione P, Ambrosio R, et al
     The role of maintenance treatment in advanced non-small-cell lung cancer: reality or early second line?
     Clin Lung Cancer. 2010;11:374-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. CIG MEDIA GROUP
     CLINICAL Lung Cancer.
     Clin Lung Cancer. 2010;11:366-9.
     PubMed     Text format     Related articles   
     
     
     
     
102. BUTTS C , Murray RN, Smith CJ, Ellis PM, et al
     A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer.
     Clin Lung Cancer. 2010;11:391-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. KAMIYOSHIHARA M , Nagashima T, Takise A, Shimizu K, et al
     Wedge tracheobronchoplasty technique for primary pulmonary carcinoma of the right upper bronchus.
     Clin Lung Cancer. 2010;11:426-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. BASTIN AJ , Karunanantham J, Lim E
     Breathlessness after pneumonectomy: consider postpneumonectomy syndrome.
     Clin Lung Cancer. 2010;11:423-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. NAGASAKI T , Tsuchiya T, Tagawa T, Honda S, et al
     Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
     Clin Lung Cancer. 2010;11:412-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
106. LANGER CJ
     Selected clinical trials in andvanced non-small-cell lung cancer.
     Clin Lung Cancer. 2010;11:358-9.
     PubMed     Text format     Related articles   
     
     
     
     
107. ZINNER RG , Saxman SB, Peng G, Monberg MJ, et al
     Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer
     Clin Lung Cancer. 2010;11:352-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. WANG Q , Lu JB, Wu B, Hao LY, et al
     Expression and clinicopathologic significance of proteolysis-inducing factor in non-small-cell lung cancer: an immunohistochemical analysis.
     Clin Lung Cancer. 2010;11:346-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. AUJOLLET N , Meyer M, Cailliod R, Combier F, et al
     High N-terminal pro-B-type natriuretic Peptide: a biomarker of lung cancer?
     Clin Lung Cancer. 2010;11:341-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. LI L , Hu M, Zhu H, Zhao W, et al
     Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non-Small-Cell Lung Cancer.
     Clin Lung Cancer. 2010;11:335-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. GRIMMINGER PP , Schneider PM, Metzger R, Vallbohmer D, et al
     Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
     Clin Lung Cancer. 2010;11:328-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. CAPONI S , Vasile E, Ginocchi L, Tibaldi C, et al
     Second-line Treatment for Non-Small-Cell Lung Cancer: One Size Does Not Fit All.
     Clin Lung Cancer. 2010;11:320-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. SUBRAMANIAN J , Morgensztern D, Govindan R
     Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
     Clin Lung Cancer. 2010;11:311-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. CHANG AJ , Bradley JD
     Clinical perspectives on dose escalation for non-small-cell lung cancer.
     Clin Lung Cancer. 2010;11:299-302.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. ALLEN D , Simons J
     Dr. David R. Gandara receives third annual addario lectureship award at international lung cancer congress.
     Clin Lung Cancer. 2010;11:298.
     PubMed     Text format     Related articles   
     
     
     
     
116. CIG MEDIA GROUP
     CLINICAL Lung Cancer.
     Clin Lung Cancer. 2010;11:290-3.
     PubMed     Text format     Related articles   
     
     
     
     
117. MYERSON JS , Iqbal SA, O'Brien ME, Popat S, et al
     Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
     Clin Lung Cancer. 2010;11:E5-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
118. KOTHARY N , Bartos JA, Hwang GL, Dua R, et al
     Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients.
     Clin Lung Cancer. 2010;11:251-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: